⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL319891 | 1.00 | — | — | |
| SCHEMBL12898220 | 1.00 | — | — | |
| SCHEMBL1783329 | 0.79 | — | — | |
| SCHEMBL1783330 | 0.79 | — | — | |
| SCHEMBL6446752 | 0.78 | CYP1A2 (0.34) | — | |
| SCHEMBL11999764 | 0.78 | CYP1A2 (0.34) | — | |
| SCHEMBL12922698 | 0.78 | CYP1A2 (0.34) | — | |
| SCHEMBL22880787 | 0.77 | — | — | |
| SCHEMBL6725107 | 0.75 | — | — | |
| SCHEMBL319288 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220175868-A1 | INHIBITION OF SARS-CoV-2 VIRUS BY ARUM PALAESTINUM | ANKH LIFE SCIENCES LIMITED (IE) | 2022-06-09 | — | — | US | disclosed |
| US-20180162822-A1 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC | 2018-06-14 | — | — | US | disclosed |
| EP-2590968-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | Novartis AG (CH) | 2013-05-15 | — | — | EP | disclosed |
| US-20130109682-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2013-05-02 | — | — | US | disclosed |
| WO-2012004217-A1 | CYCLIC ETHER COMPOUNDS USEFUL AS KINASE INHIBITORS | NOVARTIS AG (CH) | 2012-01-12 | — | — | WO | disclosed |
| US-8039025-B1 | Methods and dosage forms for the treatment of human cancers | Life Plus, LLC (US) | 2011-10-18 | — | — | US | disclosed |
| US-4315032-A | ANTITHROMBOGENIC AGENTS, ANTIULCER AGENTS | TEITIN LIMITED (JP) | 1982-02-09 | — | — | US | disclosed |
| EP-0010287-B1 | GAMMA-AZOLYL COMPOUNDS, GROWTH REGULATING COMPOSITIONS, PROCESS FOR PRODUCING THEM AND PROCESS FOR REGULATING THE GROWTH OF PLANTS | BASF Aktiengesellschaft (DE) | 1981-08-05 | — | — | EP | disclosed |
| US-4278800-A | γ-Azolyl compounds, agents containing them for regulating plant growth, and the manufacture thereof | BASF AKTIENGESELLSCHAFT (DE) | 1981-07-14 | — | — | US | disclosed |
| EP-0019475-A2 | Process for preparing adjacently disubstituted ketones, novel prostaglandins E1 and anti-thrombotic compositions containing them | TEIJIN LIMITED (JP) | 1980-11-26 | — | — | EP | disclosed |
| EP-0010287-A1 | Gamma-azolyl compounds, growth regulating compositions, process for producing them and process for regulating the growth of plants | BASF Aktiengesellschaft (DE) | 1980-04-30 | — | — | EP | disclosed |
| US-4139717-A | 1,3-Dicarbonyl compounds | TEIJIN LIMITED (JP) | 1979-02-13 | — | — | US | disclosed |
| US-4009196-A | HYPOTENSIVE AGENTS, BRONCHODILATORS, PROSTAGLANDIN ANALOGS | TEIJIN LIMITED (JA) | 1977-02-22 | — | — | US | disclosed |